文献
J-GLOBAL ID:202002279805756857
整理番号:20A2460158
チロシンキナーゼ阻害剤の第一選択治療を受けているEGFR変異を伴う転移性肺腺癌患者の進行パターンと失敗部位の解析【JST・京大機械翻訳】
Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors
著者 (9件):
Li Xiao-yang
(Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China)
,
Li Xiao-yang
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Zhu Xue-ru
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Zhang Chen-chen
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Yu Wen
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Zhang Bo
(Pulmonary Department, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Shen Tian-le
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
,
Zhang Hong-yan
(Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China)
,
Fu Xiao-long
(Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
21
号:
6
ページ:
534-544
発行年:
2020年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)